• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖通过直接作用于小鼠胰腺α细胞来抑制胰高血糖素分泌。

Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells.

作者信息

Vieira E, Salehi A, Gylfe E

机构信息

Department of Medical Cell Biology, Uppsala University, BMC Box 571, SE-751 23, Uppsala, Sweden.

出版信息

Diabetologia. 2007 Feb;50(2):370-9. doi: 10.1007/s00125-006-0511-1. Epub 2006 Nov 29.

DOI:10.1007/s00125-006-0511-1
PMID:17136393
Abstract

AIMS/HYPOTHESIS: The mechanisms by which glucose regulates glucagon release are poorly understood. The present study aimed to clarify the direct effects of glucose on the glucagon-releasing alpha cells and those effects mediated by paracrine islet factors.

MATERIALS AND METHODS

Glucagon, insulin and somatostatin release were measured from incubated mouse pancreatic islets and the cytoplasmic Ca(2+) concentration (Ca(2+)) recorded in isolated mouse alpha cells.

RESULTS

Glucose inhibited glucagon release with maximal effect at 7 mmol/l. Since this concentration corresponded to threshold stimulation of insulin secretion, it is unlikely that inhibition of glucagon secretion is mediated by beta cell factors. Although somatostatin secretion data seemed consistent with a role of this hormone in glucose-inhibited glucagon release, a somatostatin receptor type 2 antagonist stimulated glucagon release without diminishing the inhibitory effect of glucose. In islets exposed to tolbutamide plus 8 mmol/l K(+), glucose inhibited glucagon secretion without stimulating the release of insulin and somatostatin, indicating a direct inhibitory effect on the alpha cells that was independent of ATP-sensitive K(+) channels. Glucose lowered Ca(2+) of individual alpha cells independently of somatostatin and beta cell factors (insulin, Zn(2+) and gamma-aminobutyric acid). Glucose suppression of glucagon release was prevented by inhibitors of the sarco(endo)plasmic reticulum Ca(2+)-ATPase, which abolished the Ca(2+)-lowering effect of glucose on isolated alpha cells.

CONCLUSIONS/INTERPRETATION: Beta cell factors or somatostatin do not seem to mediate glucose inhibition of glucagon secretion. We instead propose that glucose has a direct inhibitory effect on mouse alpha cells by suppressing a depolarising Ca(2+) store-operated current.

摘要

目的/假设:葡萄糖调节胰高血糖素释放的机制尚不清楚。本研究旨在阐明葡萄糖对释放胰高血糖素的α细胞的直接作用以及旁分泌胰岛因子介导的那些作用。

材料与方法

从小鼠胰岛孵育物中测量胰高血糖素、胰岛素和生长抑素的释放,并记录分离的小鼠α细胞中的细胞质Ca(2+)浓度([Ca(2+)]i)。

结果

葡萄糖抑制胰高血糖素释放,在7 mmol/l时效果最大。由于该浓度对应于胰岛素分泌的阈值刺激,因此胰高血糖素分泌的抑制不太可能由β细胞因子介导。尽管生长抑素分泌数据似乎与该激素在葡萄糖抑制的胰高血糖素释放中的作用一致,但2型生长抑素受体拮抗剂刺激了胰高血糖素释放,而没有减弱葡萄糖的抑制作用。在暴露于甲苯磺丁脲加8 mmol/l K(+)的胰岛中,葡萄糖抑制胰高血糖素分泌,而不刺激胰岛素和生长抑素的释放,表明对α细胞有直接抑制作用,且独立于ATP敏感性钾通道。葡萄糖降低单个α细胞的[Ca(2+)]i,独立于生长抑素和β细胞因子(胰岛素、Zn(2+)和γ-氨基丁酸)。肌浆网Ca(2+)-ATP酶抑制剂可阻止葡萄糖对胰高血糖素释放的抑制作用,该抑制剂消除了葡萄糖对分离的α细胞的[Ca(2+)]i降低作用。

结论/解读:β细胞因子或生长抑素似乎不介导葡萄糖对胰高血糖素分泌的抑制作用。相反,我们提出葡萄糖通过抑制去极化的Ca(2+)储存操纵电流对小鼠α细胞有直接抑制作用。

相似文献

1
Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells.葡萄糖通过直接作用于小鼠胰腺α细胞来抑制胰高血糖素分泌。
Diabetologia. 2007 Feb;50(2):370-9. doi: 10.1007/s00125-006-0511-1. Epub 2006 Nov 29.
2
Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets.电压门控离子通道的膜电位依赖性失活可抑制人胰岛α细胞的胰高血糖素分泌。
Diabetes. 2010 Sep;59(9):2198-208. doi: 10.2337/db09-1505. Epub 2010 Jun 14.
3
K channel blockers control glucagon secretion by distinct mechanisms: A direct stimulation of α-cells involving a [Ca] rise and an indirect inhibition mediated by somatostatin.K 通道阻滞剂通过不同的机制控制胰高血糖素的分泌:一种是通过 [Ca] 上升直接刺激α细胞,另一种是通过生长抑素介导的间接抑制。
Mol Metab. 2021 Nov;53:101268. doi: 10.1016/j.molmet.2021.101268. Epub 2021 Jun 9.
4
Glucose inhibits glucagon secretion by decreasing [Ca] and by reducing the efficacy of Ca on exocytosis via somatostatin-dependent and independent mechanisms.葡萄糖通过降低细胞内钙离子浓度[Ca]以及通过生长抑素依赖和非依赖的机制减少钙离子对胞吐作用的效率来抑制胰高血糖素的分泌。
Mol Metab. 2022 Jul;61:101495. doi: 10.1016/j.molmet.2022.101495. Epub 2022 Apr 11.
5
Oleic acid glucose-independently stimulates glucagon secretion by increasing cytoplasmic Ca2+ via endoplasmic reticulum Ca2+ release and Ca2+ influx in the rat islet alpha-cells.油酸通过内质网钙释放和钙内流增加细胞质钙离子浓度,从而在不依赖葡萄糖的情况下刺激大鼠胰岛α细胞分泌胰高血糖素。
Endocrinology. 2007 May;148(5):2496-504. doi: 10.1210/en.2006-1156. Epub 2007 Feb 8.
6
Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of K(ATP) channels from both α-cells and δ-cells.甲苯磺丁脲对小鼠胰岛释放胰高血糖素的作用不同于葡萄糖:涉及到 α 细胞和 δ 细胞的 K(ATP)通道。
Diabetes. 2013 May;62(5):1612-22. doi: 10.2337/db12-0347. Epub 2013 Feb 4.
7
Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice.游离脂肪酸受体 4 在δ细胞中的抑制性信号转导调节小鼠胰岛激素的分泌。
Mol Metab. 2021 Mar;45:101166. doi: 10.1016/j.molmet.2021.101166. Epub 2021 Jan 20.
8
Glucose controls glucagon secretion by directly modulating cAMP in alpha cells.葡萄糖通过直接调节α细胞中的 cAMP 来控制胰高血糖素的分泌。
Diabetologia. 2019 Jul;62(7):1212-1224. doi: 10.1007/s00125-019-4857-6. Epub 2019 Apr 5.
9
TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion.TALK-1 降低 δ 细胞内质网和细胞质中的钙水平,从而限制生长抑素的分泌。
Mol Metab. 2018 Mar;9:84-97. doi: 10.1016/j.molmet.2018.01.016. Epub 2018 Jan 31.
10
Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.低血糖浓度时胰高血糖素分泌的调节:三磷酸腺苷敏感性钾通道参与的证据。
Endocrinology. 2005 Dec;146(12):5514-21. doi: 10.1210/en.2005-0637. Epub 2005 Aug 25.

引用本文的文献

1
Islet hormones at the intersection of glucose and amino acid metabolism.胰岛激素处于葡萄糖和氨基酸代谢的交叉点。
Nat Rev Endocrinol. 2025 Mar 7. doi: 10.1038/s41574-025-01100-4.
2
Real-time detection of somatostatin release from single islets reveals hypersecretion in type 2 diabetes.对单个胰岛中生长抑素释放的实时检测揭示了2型糖尿病中的分泌亢进。
Acta Physiol (Oxf). 2025 Feb;241(2):e14268. doi: 10.1111/apha.14268.
3
Pancreatic δ Cells: An Overlooked Cell in Focus.胰腺 δ 细胞:被忽视的焦点细胞。

本文引用的文献

1
Paradoxical stimulation of glucagon secretion by high glucose concentrations.高血糖浓度对胰高血糖素分泌的反常刺激。
Diabetes. 2006 Aug;55(8):2318-23. doi: 10.2337/db06-0080.
2
Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system.胰岛内胰岛素通过γ-氨基丁酸-GABAA受体系统抑制胰高血糖素释放。
Cell Metab. 2006 Jan;3(1):47-58. doi: 10.1016/j.cmet.2005.11.015.
3
Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.
Adv Anat Embryol Cell Biol. 2024;239:141-155. doi: 10.1007/978-3-031-62232-8_6.
4
Abnormal late postprandial glucagon response in type 1 diabetes is a function of differences in stimulated C-peptide concentrations.1 型糖尿病患者餐后胰高血糖素反应异常是受刺激的 C 肽浓度差异的功能。
Front Endocrinol (Lausanne). 2024 Aug 1;15:1419329. doi: 10.3389/fendo.2024.1419329. eCollection 2024.
5
Regulatory Role of Fatty Acid Metabolism on Glucose-Induced Changes in Insulin and Glucagon Secretion by Pancreatic Islet Cells.脂肪酸代谢对胰岛细胞胰岛素和胰高血糖素分泌受葡萄糖刺激变化的调节作用。
Int J Mol Sci. 2024 May 31;25(11):6052. doi: 10.3390/ijms25116052.
6
Leucine Suppresses α-Cell cAMP and Glucagon Secretion via a Combination of Cell-Intrinsic and Islet Paracrine Signaling.亮氨酸通过细胞内固有和胰岛旁分泌信号的组合抑制α细胞的 cAMP 和胰高血糖素分泌。
Diabetes. 2024 Sep 1;73(9):1426-1439. doi: 10.2337/db23-1013.
7
The endoplasmic reticulum plays a key role in α-cell intracellular Ca dynamics and glucose-regulated glucagon secretion in mouse islets.内质网在小鼠胰岛α细胞的细胞内钙动态变化以及葡萄糖调节的胰高血糖素分泌中起关键作用。
iScience. 2024 Apr 5;27(5):109665. doi: 10.1016/j.isci.2024.109665. eCollection 2024 May 17.
8
Urocortin 3 contributes to paracrine inhibition of islet alpha cells in mice.尿皮质素3有助于对小鼠胰岛α细胞进行旁分泌抑制。
J Endocrinol. 2024 May 2;261(3). doi: 10.1530/JOE-24-0018. Print 2024 Jun 1.
9
Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes.通过药物抑制生长抑素受体2以恢复糖尿病患者的胰高血糖素反调节作用。
Front Pharmacol. 2024 Jan 17;14:1295639. doi: 10.3389/fphar.2023.1295639. eCollection 2023.
10
Paracrine signalling by pancreatic δ cells determines the glycaemic set point in mice.胰岛 δ 细胞的旁分泌信号决定了小鼠的血糖设定点。
Nat Metab. 2024 Jan;6(1):61-77. doi: 10.1038/s42255-023-00944-2. Epub 2024 Jan 9.
低血糖浓度时胰高血糖素分泌的调节:三磷酸腺苷敏感性钾通道参与的证据。
Endocrinology. 2005 Dec;146(12):5514-21. doi: 10.1210/en.2005-0637. Epub 2005 Aug 25.
4
Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells.葡萄糖通过类似于β细胞中刺激-分泌偶联的机制刺激单个大鼠α细胞释放胰高血糖素。
Endocrinology. 2005 Nov;146(11):4861-70. doi: 10.1210/en.2005-0800. Epub 2005 Aug 4.
5
Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells.葡萄糖调节的胰高血糖素分泌需要胰腺α细胞中胰岛素受体的表达。
J Biol Chem. 2005 Sep 30;280(39):33487-96. doi: 10.1074/jbc.M506276200. Epub 2005 Jul 14.
6
Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor.缺乏1型磺脲类受体的小鼠胰高血糖素分泌反应受损。
Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E570-7. doi: 10.1152/ajpendo.00102.2005. Epub 2005 Jun 7.
7
Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release.β细胞分泌产物激活α细胞的ATP依赖性钾通道以抑制胰高血糖素释放。
Diabetes. 2005 Jun;54(6):1808-15. doi: 10.2337/diabetes.54.6.1808.
8
Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells.葡萄糖或胰岛素,但不是锌离子,可抑制小鼠胰腺α细胞分泌胰高血糖素。
Diabetes. 2005 Jun;54(6):1789-97. doi: 10.2337/diabetes.54.6.1789.
9
Functional identification and monitoring of individual alpha and beta cells in cultured mouse islets of Langerhans.培养的小鼠胰岛中单个α细胞和β细胞的功能鉴定与监测。
Acta Diabetol. 2004 Dec;41(4):185-93. doi: 10.1007/s00592-004-0164-9.
10
ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse alpha-cells.野生型和SUR1基因敲除小鼠α细胞中ATP敏感性钾通道依赖的葡萄糖对胰高血糖素释放和电活动的调节
Diabetes. 2004 Dec;53 Suppl 3:S181-9. doi: 10.2337/diabetes.53.suppl_3.s181.